Compare CRGO & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CRGO | ONCY |
|---|---|---|
| Founded | 2012 | 1998 |
| Country | Spain | Canada |
| Employees | 378 | N/A |
| Industry | Blank Checks | Pharmaceuticals and Biotechnology |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 87.2M | 94.0M |
| IPO Year | N/A | 2002 |
| Metric | CRGO | ONCY |
|---|---|---|
| Price | $2.05 | $1.11 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | $2.40 | ★ $7.33 |
| AVG Volume (30 Days) | 103.1K | ★ 890.4K |
| Earning Date | 05-26-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $10.61 | N/A |
| Revenue Next Year | $16.85 | $2,505.00 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.17 | $0.33 |
| 52 Week High | $4.24 | $1.51 |
| Indicator | CRGO | ONCY |
|---|---|---|
| Relative Strength Index (RSI) | 68.15 | 60.16 |
| Support Level | $1.96 | $1.10 |
| Resistance Level | $2.46 | $1.34 |
| Average True Range (ATR) | 0.16 | 0.08 |
| MACD | 0.05 | 0.02 |
| Stochastic Oscillator | 82.31 | 100.00 |
Freightos Ltd operates as a vendor-neutral booking and payment platform for international freight. Its platform supports supply chain efficiency and agility by enabling real-time procurement of ocean and air shipping across more than ten thousand importers/exporters. forwarders, and dozens of airlines and ocean carriers. WebCargo by Freightos is a freight platform connecting carriers and forwarders in particular an air cargo eBooking platform. Freightos.com is a digital international freight marketplace for importers and exporters for instant pricing, booking, and shipment management. The company operates in two segments-Platform segment and Solutions segment. Geographically, the company operates in Europe, Hong Kong, United States which is majority revenue generator and others.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.